Evidence map›Paper›PMID 26083761›Full record

ArticlePediatric research2015

Bifidobacterium breve alters immune function and ameliorates DSS-induced inflammation in weanling rats.

Hirohisa Izumi, Mario Minegishi, Yohei Sato, Takashi Shimizu, Kazunori Sekine, Mitsunori Takase

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Pediatric research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Foods (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
  4. Composition and evolutionary characterization of the gut microbiota in pigs.International microbiology : the official journal of the Spanish Society for Microbiology · 2024
    Article
  5. Article
  6. Anti-Amnesic Effect of Synbiotic Supplementation ContainingInternational journal of molecular sciences · 2022
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. A murine model of pediatric inflammatory bowel disease causes microbiota-gut-brain axis deficits in adulthood.American journal of physiology. Gastrointestinal and liver physiology · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Effects ofWorld journal of gastroenterology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hirohisa IzumiNutritional Science Institute, Morinaga Milk Industry Co., Ltd., Higashihara, Zama-City, Kanagawa-Pref, Japan.
Mario MinegishiNutritional Science Institute, Morinaga Milk Industry Co., Ltd., Higashihara, Zama-City, Kanagawa-Pref, Japan.
Yohei SatoNutritional Science Institute, Morinaga Milk Industry Co., Ltd., Higashihara, Zama-City, Kanagawa-Pref, Japan.
Takashi ShimizuNutritional Science Institute, Morinaga Milk Industry Co., Ltd., Higashihara, Zama-City, Kanagawa-Pref, Japan.
Kazunori SekineNutritional Science Institute, Morinaga Milk Industry Co., Ltd., Higashihara, Zama-City, Kanagawa-Pref, Japan.
Mitsunori TakaseNutritional Science Institute, Morinaga Milk Industry Co., Ltd., Higashihara, Zama-City, Kanagawa-Pref, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBifidobacterium breve M-16V (M16V) is a probiotic bacterial strain with a long tradition of use in neonatal intensive care units in some countries. Previous study showed that the effects of M16V administration on gene expression were greater during the weaning period than in the neonatal period and were greater in the colon than in the small intestine and spleen, suggesting that M16V has anti-inflammatory effects. In this study, we evaluated the effects of inflammation during the weaning period and the effects of M16V on normal and inflammatory conditions.

methodsFrom postnatal day (PD) 21 to 34, weanling rats were administered of 2.5 × 10(9) of M16V daily, and colitis was induced by administration of 2% dextran sulfate sodium from PD28 to 35. Colitis severity, immune function, and microbiota were investigated.

resultsColitis caused a reduction in body weight gain, colon shortening, poor nutritional status, anemia, changes in blood and spleen lymphocyte populations, spleen T-cell malfunctions, and alterations in colon microbiota. M16V administration improved some but not all of the changes induced by colitis.

conclusionM16V could suppress inflammation and, therefore, can be considered a safe strain to use not only during the neonatal period but also the weaning period.

Indexed as

Dextran SulfateProbioticsWeaningAnimal Nutritional Physiological PhenomenaAnimalsAnimals, NewbornBifidobacteriumCells, CulturedColitisColonDisease Models, AnimalGastrointestinal MicrobiomeNutritional StatusRats, Inbred F344Severity of Illness IndexTime FactorsDextran Sulfate

Identifiers

PMID26083761
OpenAlexW2261084809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.